Evidence map›Paper›PMID 36693820›Full record

ArticleACS applied bio materials2023

Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles.

Hamed Nosrati, Marziyeh Salehiabar, Jalil Charmi, Kadir Yaray, Mohammadreza Ghaffarlou, Esra Balcioglu, Yavuz Nuri Ertas

Open access · hybridAbstract read
In one paragraph

Article in ACS applied bio materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Application of nanoparticles in breast cancer treatment: a systematic review.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Pooled it
  3. Review
  4. Article
  5. Lanthanide Nanotheranostics in Radiotherapy.International journal of molecular sciences · 2025
    Review
  6. Review
  7. State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hamed NosratiERNAM─Nanotechnology Research and Application Center, Erciyes University, Kayseri39039, Türkiye.ORCID 0000-0002-7487-8188
Marziyeh SalehiabarERNAM─Nanotechnology Research and Application Center, Erciyes University, Kayseri39039, Türkiye.
Jalil CharmiERNAM─Nanotechnology Research and Application Center, Erciyes University, Kayseri39039, Türkiye.
Kadir YarayDepartment of Radiation Oncology, Faculty of Medicine, Erciyes University, Kayseri39039, Türkiye.
Mohammadreza GhaffarlouDepartment of Chemistry, Hacettepe University, Beytepe, Ankara06532, Türkiye.
Esra BalciogluDepartment of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri39039, Türkiye.
Yavuz Nuri ErtasERNAM─Nanotechnology Research and Application Center, Erciyes University, Kayseri39039, Türkiye.ORCID 0000-0002-6791-7484
Erciyes University · TRBilkent University · TRHacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy has demonstrated promising effectiveness against several types of cancers. X-ray radiation therapy can be made further effective by utilizing nanoparticles of high-atomic-number (high-Z) materials that act as radiosensitizers. Here, in purpose of maximizing the radiation therapy within tumors, bovine serum albumin capped gadolinium oxide and gold nanoparticles (Gd

Indexed as

Metal NanoparticlesNeoplasmsRadiation-Sensitizing AgentsAnimalsBreast NeoplasmsGadoliniumGoldMiceSerum Albumin, BovineGadoliniumgadolinium oxideGoldRadiation-Sensitizing AgentsSerum Albumin, Bovinebimetallicgadoliniumgoldnanoparticleradiosensitizerradiotherapy

Identifiers

PMID36693820
PMCPMC9945098
OpenAlexW4317876157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.